U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07793214) titled 'ET-SPACE Whole-Body Infrared Hyperthermia in Patients With Advanced Solid Tumors' on Aug. 25.
Brief Summary: This ambispective observational cohort study will evaluate biological changes, palliative outcomes, and safety associated with ET-SPACE whole-body infrared hyperthermia in patients with advanced solid tumors. This noninvasive treatment uses infrared energy to raise body temperature in a controlled manner. Patients who received the treatment between January 1, 2022, and December 31, 2028, will be included. Earlier cases will be assessed retrospectively using medical records, while subsequently enrolled patients will be followe...